Aviko Radiopharmaceuticals is a privately held biotechnology company developing medicines to unlock the potential of boron neutron capture therapy (BNCT) to treat a wide variety of cancers. Aviko’s innovative compounds are designed to improve the efficacy of BNCT by targeting and delivering boron to cancer cells with precision. Together with their partners, Aviko is advancing BNCT as a safe, efficacious and convenient treatment modality for patients. Founded by Deerfield Management, Aviko is based at Cure., a healthcare innovation campus in New York City.
View Top Employees from Aviko Radiopharmaceuticals| Website | https://avikobnct.com |
| Employees | 1 (1 on RocketReach) |
| Address | 345 Park Ave S, New York, New York 10010, US |
| Industry | Biotechnology Research |
Looking for a particular Aviko Radiopharmaceuticals employee's phone or email?
Aviko Radiopharmaceuticals Questions
David Greenwald is the CEO of Aviko Radiopharmaceuticals.
1 people are employed at Aviko Radiopharmaceuticals.
Aviko Radiopharmaceuticals is based in New York, New York.
Top Aviko Radiopharmaceuticals Employees
-
5+5+
Related Companies
